iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Option Chain

Add as a Preferred Source on Google
₹2,298.7
(-1.72%)
Oct 30, 2026|03:57:43 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,880₹3 -45.45%7,8755%
--1,920₹3.05 15.09%9,3754.16%
--1,940₹4.45 0%12,7500%
--1,960₹4.4 7.31%9,000-4%
--1,980₹5.9 0%4,8750%
1,5000%₹290 0%2,000₹5.35 -0.92%15,00060%
--2,020₹5.6 -35.26%4,875-7.14%
--2,040₹8.95 0%1,1250%
--2,060₹8.95 9.81%14,250-9.52%
12,3750%₹168.2 0%2,080₹10.1 2.53%8,250-4.34%
--2,100₹12.35 8.33%81,375-27.66%
7500%₹174.5 0%2,120₹13.55 1.87%7,8750%
3750%₹152.15 0%2,140₹17.6 10%24,37520.37%
13,8750%₹175 0%2,160₹20.95 11.73%17,62517.5%
9,0000%₹140 0%2,180₹24.85 0.2%4,87562.5%
98,250-0.38%₹153.5 -6.6%2,200₹29.7 14.89%1,05,37513.30%
9,0000%₹147.2 0%2,220₹30.15 -3.52%15,7500%
24,3750%₹125.9 0%2,240₹40.6 10.62%19,5008.33%
15,000-4.76%₹109.7 -4.98%2,260₹47 12.03%55,125-6.96%
45,375-2.41%₹97.25 -9.74%2,280₹48.5 -0.51%13,1250%
3,14,6251.20%₹84.25 -12.33%2,300₹63.95 13.68%2,18,625-0.85%
1,32,3754.43%₹74.1 -11.41%2,320₹85.55 0%7,1250%
60,37531.96%₹65.15 -11.23%2,340₹84 14.44%18,00029.72%
15,75082.60%₹57.6 -11.85%2,360₹135.4 0%1,5000%
16,50041.93%₹49.15 -13.54%2,380--
2,13,750-0.69%₹41.3 -14.75%2,400₹110 0%12,3750%
7,5000%₹27.65 0%2,420--
23,25016.98%₹31.1 -12.51%2,440--
35,2500%₹30.35 -1.62%2,460₹172.6 0%7500%
16,50018.91%₹22.3 -1.32%2,480--
1,53,75079.82%₹18.6 -14.67%2,500₹187 0.53%2,2500%
19,875-1.85%₹15.9 -15.87%2,520₹270 0%1,8750%
9,37513.63%₹13.45 -17.23%2,540--
10,5003.70%₹11.85 -14.44%2,560₹310 0%2,2500%
13,8755.71%₹9.95 -17.08%2,580--
46,50087.87%₹8.6 -16.09%2,600₹440 0%3750%
30,00025%₹5.1 -13.55%2,680₹435 0%2,6250%
00%₹71.2 0%2,720--

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.